Drug companies are lowering insulin prices but it’s not $35 for everyone
Eli Lilly, Novo Nordisk and Sanofi recently announced plans to cut prices of some of their insulins — but a $35 cap on the medication doesn’t apply to all.
Eli Lilly, Novo Nordisk and Sanofi recently announced plans to cut prices of some of their insulins — but a $35 cap on the medication doesn’t apply to all.